Mangalam Drugs & Organics Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 1,198.3 million compared to INR 907.87 million a year ago. Revenue was INR 1,209.56 million compared to INR 929.01 million a year ago. Net income was INR 66.92 million compared to INR 21.54 million a year ago. Basic earnings per share from continuing operations was INR 4.23 compared to INR 1.36 a year ago. Diluted earnings per share from continuing operations was INR 4.23 compared to INR 1.36 a year ago.